###begin article-title 0
###xml 81 98 <span type="species:ncbi:12073">Coxsackievirus B4</span>
Toll-Like Receptor 3 Signaling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection
###end article-title 0
###begin p 1
Conceived and designed the experiments: MJR MSH. Performed the experiments: MJR DJL IS. Analyzed the data: MJR MSH. Wrote the paper: MJR MSH.
###end p 1
###begin p 2
###xml 384 401 <span type="species:ncbi:12073">coxsackievirus B4</span>
###xml 403 406 <span type="species:ncbi:12073">CB4</span>
###xml 421 426 <span type="species:ncbi:9606">human</span>
###xml 604 607 <span type="species:ncbi:12073">CB4</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 1445 1448 <span type="species:ncbi:12073">CB4</span>
Toll-like receptor 3 (TLR3) has been proposed to play a central role in the early recognition of viruses by sensing double stranded RNA, a common intermediate of viral replication. However, several reports have demonstrated that TLR3 signaling is either dispensable or even harmful following infection with certain viruses. Here, we asked whether TLR3 plays a role in the response to coxsackievirus B4 (CB4), a prevalent human pathogen that has been associated with pancreatitis, myocarditis and diabetes. We demonstrate that TLR3 signaling on macrophages is critical to establish protective immunity to CB4. TLR3 deficient mice produced reduced pro-inflammatory mediators and are unable to control viral replication at the early stages of infection resulting in severe cardiac damage. Intriguingly, the absence of TLR3 did not affect the activation of several key innate and adaptive cellular effectors. This suggests that in the absence of TLR3 signaling on macrophages, viral replication outpaces the developing adaptive immune response. We further demonstrate that the MyD88-dependent signaling pathways are not only unable to compensate for the loss of TLR3, they are also dispensable in the response to this RNA virus. Our results demonstrate that TLR3 is not simply part of a redundant system of viral recognition, but rather TLR3 plays an essential role in recognizing the molecular signatures associated with specific viruses including CB4.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 433 436 433 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Boehme1">[1]</xref>
###xml 437 440 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Triantafilou1">[3]</xref>
###xml 478 481 478 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Alexopoulou1">[4]</xref>
###xml 482 485 482 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Lund1">[7]</xref>
Protective immunity to viral infection is often critically dependent on early recognition of the pathogen. This first-line of defense against viral infection is mediated, in part, by a series of pattern-recognition receptors that include Toll-like receptors (TLRs) and Rig-like helicases (RLH). TLRs act as sensors that can recognize several molecular patterns associated with viruses including surface glycoproteins (TLR1, 2 and 4) [1]-[3] and nucleic acids (TLR3, 7, 8 and 9) [4]-[7]. Recognition of a cognate ligand induces a downstream signaling cascade culminating in the release of pro-inflammatory cytokines and maturation of antigen presenting cells (APCs). As such, TLR signaling contributes to the establishment of an anti-viral state and, by activating APCs, to the establishment of an adaptive anti-viral response.
###end p 4
###begin p 5
###xml 190 193 190 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Alexopoulou1">[4]</xref>
###xml 487 490 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Oshiumi1">[8]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Hoebe1">[10]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Ichinohe1">[11]</xref>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Ashkar1">[16]</xref>
###xml 672 679 672 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1141 1145 1141 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Hardarson1">[17]</xref>
###xml 1243 1247 1243 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Tabeta1">[18]</xref>
###xml 1269 1273 1269 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-McCartney1">[19]</xref>
###xml 1508 1512 1508 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Tabeta1">[18]</xref>
###xml 1697 1701 1697 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Zhang1">[20]</xref>
###xml 1920 1924 1920 1924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Schulz1">[21]</xref>
###xml 2292 2296 2292 2296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Edelmann1">[22]</xref>
###xml 2448 2452 2448 2452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Carpentier1">[23]</xref>
###xml 2715 2719 2715 2719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-LeGoffic1">[24]</xref>
###xml 2863 2867 2863 2867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Gowen1">[25]</xref>
###xml 3181 3185 3181 3185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Wang1">[26]</xref>
###xml 3313 3317 3313 3317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Daffis1">[27]</xref>
###xml 817 843 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
###xml 845 849 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1066 1070 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1099 1103 <span type="species:ncbi:10090">mice</span>
###xml 1214 1219 <span type="species:ncbi:10090">mouse</span>
###xml 1237 1241 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1252 1268 <span type="species:ncbi:357231">murine norovirus</span>
###xml 1292 1296 <span type="species:ncbi:10090">mice</span>
###xml 1464 1468 <span type="species:ncbi:10090">mice</span>
###xml 1503 1507 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 1572 1580 <span type="species:ncbi:9606">patients</span>
###xml 2015 2019 <span type="species:ncbi:10090">mice</span>
###xml 2117 2151 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
###xml 2153 2157 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 2160 2186 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 2194 2198 <span type="species:ncbi:10366?0.7619047619047619|species:ncbi:12138?0.0056022408963585435">MCMV</span>
###xml 2204 2212 <span type="species:ncbi:10891">reovirus</span>
###xml 2410 2416 <span type="species:ncbi:10090">murine</span>
###xml 2755 2759 <span type="species:ncbi:10090">mice</span>
###xml 2935 2950 <span type="species:ncbi:11082">West Nile virus</span>
###xml 3263 3278 <span type="species:ncbi:11082">West Nile virus</span>
TLR3 has long been proposed to play an important role in the innate response to viruses due to its capacity to recognize double stranded (ds) RNA, a common intermediate of viral replication [4]. Binding of dsRNA to TLR3 initiates a unique signaling cascade that, unlike other TLR ligands (with the exception of some TLR4 ligands that can initiate two separate signaling pathways) does not depend on the signaling adaptor MyD88 but rather utilizes the molecular adaptor TRIF (or TICAM-1) [8]-[10]. Despite the well documented capacity of Poly I:C, a synthetic mimic of dsRNA, to increase antiviral immunity in a TLR3 dependent manner [11]-[16], the protective role of TLR3 in vivo remains controversial. For instance, a protective role for TLR3 has been demonstrated in a model of viral induced myocarditis. Following encephalomyocarditis virus (EMCV) challenge, TLR3 deficiency resulted in heightened mortality that correlated with increased viral replication and viral mediated cardiac damage. However, in this study TLR3 signaling was only partially protective as EMCV infection of wild-type (WT) mice still resulted in over 75% mortality [17]. TLR3 was also shown to play a minor role in the immune response to mouse cytomegalovirus (MCMV) [18] and murine norovirus [19] as TLR3 deficient mice were observed to harbor increased viral titers following infection although this did not affect their capacity to survive viral infection. In contrast, TLR9 deficient mice rapidly succumbed to infection by MCMV [18]. Furthermore, a dominant negative TLR3 allele was found in patients suffering from Herpes Simplex encephalitis implying a role for this receptor in protection from neurotropic viruses [20]. TLR3 signaling may be of particular importance for the immune responses to viruses that do not directly infect dendritic cells (DCs) as it was demonstrated to promote cross-priming of CD8 T cells in response to dsRNA [21]. Conversely, Edelmann and colleagues have reported that in the absence of TLR3 signaling, mice can still mount a protective immune response following challenge with various viruses, including lymphocytic choriomeningitis virus (LCMV), vesicular stomatitis virus (VSV), MCMV, and reovirus, resulting in unaffected viral clearance and no increase in viral pathogenesis [22]. Further, it was reported that TLR3 does not play a major role in the immune response of astrocytes to Theiler's murine encephalomyelitis virus (TMEV) [23]. Intriguingly, TLR3 has been observed to play a deleterious role towards the host following pathogen challenge in several models. TLR3 deficiency has been reported to confer a survival advantage following influenza A challenge due to a reduction in inflammation [24] and was also determined to protect mice following challenge with lethal doses of Punta Toro Virus by reducing viral-induced liver pathogenesis [25]. Furthermore, TLR3 deficiency was shown to be beneficial following West Nile virus infection. It was demonstrated that while the absence of TLR3 signaling resulted in increased peripheral viral load it also served to reduce neural inflammation leading to a decrease in both viral loads and pathology in the brain [26]. Conversely, a recent report has suggested that TLR3 may act to protect from West Nile virus infection directly within neurons [27]. Taken together, these data demonstrate that TLR3 may only be required for the response to a specific subset of viruses. Further, multiple reports suggest that TLR3 signaling is either dispensable or even harmful following infection with other RNA viruses.
###end p 5
###begin p 6
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Richer1">[28]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Rose1">[29]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Wang1">[26]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Taylor1">[30]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Yoon1">[31]</xref>
###xml 680 684 680 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Richer2">[32]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Serreze1">[33]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Horwitz1">[34]</xref>
###xml 983 986 983 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Triantafilou1">[3]</xref>
###xml 1065 1068 1065 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Triantafilou2">[5]</xref>
###xml 1337 1344 1337 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 17 <span type="species:ncbi:12073">Coxsackievirus B4</span>
###xml 19 22 <span type="species:ncbi:12073">CB4</span>
###xml 510 513 <span type="species:ncbi:12073">CB4</span>
###xml 545 552 <span type="species:ncbi:9606">patient</span>
###xml 675 679 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 929 932 <span type="species:ncbi:12073">CB4</span>
###xml 1262 1266 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1323 1326 <span type="species:ncbi:12073">CB4</span>
Coxsackievirus B4 (CB4) is a small, single stranded, positive sense RNA picornavirus with tropism for the pancreas, where it has been associated with induction of pancreatitis and autoimmune diabetes (reviewed in [28]), and the heart where it can cause both acute and chronic myocarditis [29]. It is estimated that coxsackieviral infections are responsible for nearly a third of all new cases of dilated cardiomyopathy a disease responsible for the majority of heart transplantations [26], [30]. Additionally, CB4 was originally isolated from a patient suffering from type 1 diabetes [31] and has been demonstrated to accelerate onset of diabetes in non-obese diabetic (NOD) mice [32], [33]. The immune response to this virus may be strongly dependent on innate mechanism as it has been previously demonstrated that SCID mice are capable of surviving infection even at high infectious doses [34]. It was previously reported that CB4 can signal through TLR4 on pancreatic islet cells [3] and that a closely related virus, CB3, signals through TLR8 on cardiomyocytes [5]. The generation of dsRNA, the ligand for TLR3, is a common by-product of the replication cycle of single stranded RNA viruses including picornaviruses like coxsackievirus and arenaviruses like LCMV. The importance of TLRs and particularly TLR3 following CB4 infection in vivo remains to be elucidated.
###end p 6
###begin p 7
###xml 55 58 <span type="species:ncbi:12073">CB4</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 806 809 <span type="species:ncbi:12073">CB4</span>
Here, we demonstrate that the early immune response to CB4 is solely dependent on TLR3 signaling as infection of TLR3 deficient but not MyD88 deficient mice had fatal consequences. We have further demonstrated that this increased mortality is due to the inability of the host to control viral replication rapidly leading to severe cardiac damage. Interestingly, TLR3 deficiency did not affect the maturation of APCs or the activation of the adaptive immune response. Rather, TLR3 deficiency decreases the production of the pro-inflammatory mediators TNF-alpha and CCL5 resulting in uncontrolled viral replication that outpaces the developing adaptive immune response. Most importantly, we demonstrate that adoptive transfer of WT macrophages is sufficient to protect TLR3 deficient mice from succumbing to CB4 infection indicating that TLR3 signaling on macrophages is critical for the host response to this RNA virus.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 50 53 <span type="species:ncbi:12073">CB4</span>
TLR3 plays a critical role for survival following CB4 infection
###end title 9
###begin p 10
###xml 520 529 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g001">Figure 1A</xref>
###xml 787 791 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Edelmann1">[22]</xref>
###xml 959 968 959 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g001">Figure 1A</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Edelmann1">[22]</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 163 166 <span type="species:ncbi:12073">CB4</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 328 331 <span type="species:ncbi:12073">CB4</span>
###xml 391 394 <span type="species:ncbi:12073">CB4</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
###xml 634 639 <span type="species:ncbi:10090">mouse</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 874 878 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1085 1088 <span type="species:ncbi:12073">CB4</span>
###xml 1152 1156 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1252 1255 <span type="species:ncbi:12073">CB4</span>
In order to elucidate the role of TLR3 in the innate immune response to coxsackievirus, NOD mice deficient for TLR3 (TLR3KO) were infected with sublethal doses of CB4 and were monitored for survival. As a control, NOD mice lacking MyD88 (MyD88KO) (and therefore unable to signal from the remaining TLRs) were also infected with CB4. We observed a significant increase in mortality following CB4 challenge in TLR3KO mice with nearly 60% of TLR3KO mice dying by day 7 compared to less than 15% of WT NOD and MyD88KO mice (Figure 1A). For comparison to other studies and to ensure that the phenotype observed was not simply dependent on mouse strain differences, mice were challenged with LCMV as TLR3 was previously demonstrated to be dispensable for the immune response to this RNA virus [22]. As previously reported, deficiency of TLR3 did not result in mortality following LCMV infection confirming that TLR3 is not necessary for the response to this virus (Figure 1A) [22]. Taken together, this suggests that while TLR3 plays a critical role in the response to some RNA viruses like CB4, it is not necessary for the control of other RNA viruses like LCMV. Importantly, the MyD88-dependent TLR signaling pathway is not required for survival following CB4 challenge, nor can it compensate for the lack of TLR3 signaling.
###end p 10
###begin title 11
###xml 92 95 <span type="species:ncbi:12073">CB4</span>
Deficiency of TLR3 results in increased mortality and increased viral replication following CB4 challenge.
###end title 11
###begin p 12
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 124 127 <span type="species:ncbi:12073">CB4</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 336 339 <span type="species:ncbi:12073">CB4</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 401 405 <span type="species:ncbi:10090">Mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 735 739 <span type="species:ncbi:10090">mice</span>
A) WT NOD (solid grey line), TLR3KO (solid black line) and MyD88KO mice (dashed black line) were challenged with 400 pfu of CB4 and mortality was monitored. TLR3KO mice were also challenged with 1x105 pfu of LCMV (dashed grey line) as an additional control. Significantly decreased survival was observed for TLR3KO mice challenged with CB4 compared to all other mouse strains and treatment tested. B) Mice were sacrificed at day 7 PI and viral load from the pancreas liver and heart of WT NOD (black bars, n = 8), TLR3KO (white bars, n = 5) or MyD88KO (grey bars, n = 6) mice were measured by standard plaque assay. The viral titers are presented as log10 pfu/g of tissue and represent the average values of duplicates from at least 4 mice in each group. Stars denote statistical significance.
###end p 12
###begin title 13
Mortality is associated with increased viral replication and increased cardiac damage
###end title 13
###begin p 14
###xml 484 493 484 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g001">Figure 1B</xref>
###xml 637 646 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g001">Figure 1B</xref>
###xml 825 834 825 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g001">Figure 1B</xref>
###xml 1112 1121 1112 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g002">Figure 2A</xref>
###xml 1468 1477 1468 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g002">Figure 2A</xref>
###xml 1623 1632 1623 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g002">Figure 2B</xref>
###xml 2128 2137 2128 2137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g002">Figure 2A</xref>
###xml 2277 2281 2277 2281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Bertinchant1">[35]</xref>
###xml 2365 2374 2365 2374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g002">Figure 2C</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 248 251 <span type="species:ncbi:12073">CB4</span>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
###xml 1106 1110 <span type="species:ncbi:10090">mice</span>
###xml 1438 1442 <span type="species:ncbi:10090">mice</span>
###xml 1453 1456 <span type="species:ncbi:12073">CB4</span>
###xml 1691 1695 <span type="species:ncbi:10090">mice</span>
###xml 1715 1719 <span type="species:ncbi:10090">mice</span>
###xml 1904 1908 <span type="species:ncbi:10090">mice</span>
###xml 2081 2085 <span type="species:ncbi:10090">mice</span>
###xml 2122 2126 <span type="species:ncbi:10090">mice</span>
###xml 2306 2310 <span type="species:ncbi:10090">mice</span>
###xml 2347 2351 <span type="species:ncbi:10090">mice</span>
In order to determine whether increased mortality in TLR3 deficient mice resulted from an inability to control viral replication, viral titers in the pancreas, liver and heart were determined by plaque assay at day 3 and 7 post-infection (PI) with CB4. No significant differences were observed at day 3 PI (data not shown). Conversely, we observed a significant increase in viral replication in the heart and liver of TLR3KO mice compared to both WT NOD and MyD88KO mice at day 7 PI (Figure 1B). We also observed increased viral replication in the pancreas of TLR3KO mice although this difference did not reach statistical significance (Figure 1B). Most notably, at day 7 PI the viral titers in the hearts of TLR3KO mice were approximately 100 and 1000 fold higher than that observed in WT NOD and MyD88KO mice respectively (Figure 1B). We next determined whether increased viral replication resulted in heightened tissue damage that might explain the rapid death observed in TLR3KO mice. Histological examination of pancreatic tissue revealed extensive damage in TLR3KO mice that was comparable to WT NOD mice (Figure 2A). Additionally, blood glucose levels were comparable in all 3 strains at day 3 and 7 PI (data not shown) suggesting that pancreatic dysfunction is unlikely to explain the increased mortality observed. Analysis of TLR3KO livers did not reveal any obvious differences in pathology compared to either WT NOD or MyD88KO mice following CB4 infection (Figure 2A). Liver damage was further analyzed at day 3 and 7 PI using a quantitative assay based on the levels of Alanine transaminase (ALT) in the serum (Figure 2B). We observed increased ALT levels in the serum of TLR3KO mice compared to WT NOD mice at day 3 and 7 PI although this difference never reached statistical significance suggesting that liver damage is not a major contributor to the observed increased mortality in TLR3KO mice. Finally, we measured the extent of cardiac damage. Histological analysis revealed an atypical increase in the number and severity of cardiac lesions at day 7 PI in TLR3KO mice compared to both WT NOD and MyD88KO mice (Figure 2A). These observations were confirmed by a significant increase in the presence of cardiac Troponin I (cTn1), a marker for myocardial injury [35], in the serum of TLR3KO mice compared to both WT NOD and MyD88KO mice at day 7 PI (Figure 2C). Taken together, these results demonstrate that the absence of signaling from TLR3 but not other TLRs leads to uncontrolled viral replication in several organs including the heart where heightened damage is most likely responsible for the observed increase in mortality.
###end p 14
###begin title 15
###xml 65 68 <span type="species:ncbi:12073">CB4</span>
TLR3 deficiency results in increased cardiac damage during acute CB4 infection.
###end title 15
###begin p 16
###xml 154 157 <span type="species:ncbi:12073">CB4</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 398 401 <span type="species:ncbi:12073">CB4</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 650 653 <span type="species:ncbi:12073">CB4</span>
A) Representative tissue section of pancreas (left column), liver (center column) or heart (right column) stained for H&E from mock-infected (top row) or CB4-infected WT NOD (second row), TLR3KO (third row) or MyD88KO (bottom row) mice at day 7 PI. B) Serum ALT levels of WT NOD (black bars), TLR3KO (white bars) or MyD88KO (grey bars) mice either mock-infected with DMEM or at day 3 and 7 PI with CB4. Pooled data from at least 2 independent experiments are presented as mean+/-s.e.m. C) Serum cardiac troponin 1 levels of WT NOD (black bars), TLR3KO (white bars) or MyD88KO (grey bars) mice either mock-infected with DMEM or at day 3 and 7 PI with CB4. Pooled data from at least 2 independent experiments are presented as mean+/-s.e.m . Stars denote statistical significance.
###end p 16
###begin title 17
###xml 85 88 <span type="species:ncbi:12073">CB4</span>
TLR3 deficiency does not affect activation of innate or adaptive effectors following CB4 infection
###end title 17
###begin p 18
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 439 440 436 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 458 459 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 471 472 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 807 819 801 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g003">Figure 3A, B</xref>
###xml 907 919 901 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s001">Figure S1A,B</xref>
###xml 1257 1265 1251 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g003">Figure 3</xref>
###xml 1672 1683 1666 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g003">Figure 3C,D</xref>
###xml 1875 1887 1869 1881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s001">Figure S1C,D</xref>
###xml 2125 2134 2119 2128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s002">Figure S2</xref>
###xml 351 354 <span type="species:ncbi:12073">CB4</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 1124 1127 <span type="species:ncbi:12073">CB4</span>
###xml 1465 1469 <span type="species:ncbi:10090">mice</span>
###xml 1666 1670 <span type="species:ncbi:10090">mice</span>
###xml 1717 1721 <span type="species:ncbi:10090">mice</span>
###xml 1797 1801 <span type="species:ncbi:10090">mice</span>
###xml 1980 1983 <span type="species:ncbi:12073">CB4</span>
###xml 2026 2030 <span type="species:ncbi:10090">mice</span>
###xml 2055 2059 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
TLR mediated signals are important for the activation of several innate effectors including NK cells and APCs. TLR signaling can also affect the activation of the adaptive immune response either directly or through effects on the APC population. As such, we sought to determine the activation status of several important antiviral effectors following CB4 infection in TLR3KO mice. First, we determined the activation of NK (pan-NK+ TCRbeta-) and NK T (pan-NK+ and TCRbeta+) cells by measuring surface expression of the activation marker CD69 by flow cytometry. At 48 hours post-infection, we observed that both NK and NKT cells from TLR3KO mice upregulated CD69 to levels comparable with WT NOD mice suggesting that these cells can respond normally to viral infection despite the absence of TLR3 signaling (Figure 3A, B). Interestingly, NK and NK T cell activation was completely abrogated in MyD88KO mice (Figure S1A,B). This highlights an important role for this pathway and other TLRs in the activation of NK and NK T cells although it also suggests that activation of these cells is not necessary for survival following CB4 challenge. We next determined the activation status of APCs by measuring surface expression of the costimulatory molecules CD80 (Figure 3) and CD86 (data not shown) on macrophages (CD11b+CD11c-) and DCs (CD11c+) at day 4 PI. We observed comparable upregulation of costimulatory molecules on macrophages and DCs in both WT NOD and TLR3KO mice demonstrating that TLR3 signaling is not necessary for the maturation of APCs and further suggest that a defect in APC maturation is not responsible for the increased mortality observed in TLR3KO mice (Figure 3C,D). Following infection of MyD88KO mice, we observed reduced maturation of both macrophages and DCs compared to WT mice again suggesting a role for the MyD88 pathway in the maturation of APCs (Figure S1C,D). These results suggest that the maturation of APCs is not necessary for survival following CB4 infection. As a control WT NOD and TLR3KO mice were also infected with LCMV and as expected, no differences in APC maturation were observed (Figure S2).
###end p 18
###begin title 19
###xml 87 90 <span type="species:ncbi:12073">CB4</span>
TLR3 deficiency does not affect the capacity of innate effectors to activate following CB4 infection.
###end title 19
###begin p 20
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 73 74 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 101 102 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 112 113 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 215 218 <span type="species:ncbi:12073">CB4</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
###xml 512 515 <span type="species:ncbi:12073">CB4</span>
Representative histograms of CD69 expression on (A) NK (Pan-NK+, TCRbeta -) or (B) NK T cells (Pan-NK+, TCRbeta +) from WT NOD (left panels) and TLR3KO (right panels) mice at 48 hours post-infection with 400 pfu of CB4 (solid black lines) or mock-infection with DMEM (shaded histogram). Representative histograms of CD80 expression on the surface of (C) macrophages (CD11b+CD11c-) and (D) dendritic cells (CD11c+) from WT NOD (left panels) and TLR3KO (right panels) mice at 4 days post-infection with 400 pfu of CB4 (solid black lines) or mock-infection with DMEM (shaded histogram). Data is representative of at least 2 separate experiments.
###end p 20
###begin p 21
###xml 442 451 442 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s003">Figure S3</xref>
###xml 656 666 656 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s001">Figure S1E</xref>
###xml 789 797 789 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g004">Figure 4</xref>
###xml 808 817 808 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s004">Figure S4</xref>
###xml 897 906 897 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s005">Figure S5</xref>
###xml 1086 1099 1086 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s001">Figure S1F, G</xref>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 547 550 <span type="species:ncbi:12073">CB4</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 784 787 <span type="species:ncbi:12073">CB4</span>
###xml 802 806 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1027 1030 <span type="species:ncbi:12073">CB4</span>
###xml 1204 1207 <span type="species:ncbi:12073">CB4</span>
###xml 1386 1389 <span type="species:ncbi:12073">CB4</span>
To determine whether TLR3 deficiency results in changes in the activation of the adaptive immune system, the activation status of B cells and T cells was monitored by flow cytometry. At day 4 PI we observed that B cells (CD19+) from TLR3KO mice responded to viral infection by upregulating surface expression of the activation marker CD69 and the costimulatory molecule CD86 to levels comparable to that observed on B cells from WT NOD mice (Figure S3). As for innate effectors, we observed reduced activation of B cells in MyD88KO mice following CB4 challenge although as opposed to what we observed for NK cells, activation was not completely abrogated (Figure S1E). Similarly, the activation status of T cells from TLR3KO mice was comparable to WT NOD mice at day 4 PI with either CB4 (Figure 4) or LCMV (Figure S4) as measured by upregulation of CD69 and downregulation of CD62L and at day 7 (Figure S5) as measured by upregulation of CD44. Consistent with the limited maturation of APCs observed in MyD88KO mice following CB4 infection, T cell activation was also greatly reduced (Figure S1F, G). This data suggests that the maturation and activation of both innate and adaptive effectors following CB4 infection is dependent on the MyD88 signaling pathway and independent of TLR3. This further suggests that activation of cellular effectors is not critical for survival following CB4 infection.
###end p 21
###begin title 22
###xml 78 81 <span type="species:ncbi:12073">CB4</span>
TLR3 deficiency does not affect the capacity of T cells to activate following CB4 infection.
###end title 22
###begin p 23
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 199 202 <span type="species:ncbi:12073">CB4</span>
Representative histograms of CD62L and CD69 expression on the surface of (A) CD4 and (B) CD8 T cells from WT NOD (left panels) and TLR3KO (right panels) mice at 4 days post-infection with 400 pfu of CB4 (solid black lines) or mock-infection with DMEM (shaded histogram). Data is representative of at least 2 separate experiments.
###end p 23
###begin title 24
TLR3 deficiency results in lower production of inflammatory mediators following infection
###end title 24
###begin p 25
###xml 319 328 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004127.s006">Figure S6</xref>
###xml 685 694 677 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5A</xref>
###xml 706 715 698 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5B</xref>
###xml 751 760 739 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5C</xref>
###xml 1050 1058 1034 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5</xref>
###xml 1518 1529 1490 1501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5B,C</xref>
###xml 1835 1839 1803 1807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Klavinskis1">[36]</xref>
###xml 1922 1931 1886 1895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5C</xref>
###xml 2054 2058 2018 2022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Zhou1">[37]</xref>
###xml 2060 2064 2024 2028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Jung1">[38]</xref>
###xml 2207 2218 2163 2174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5A,B</xref>
###xml 2299 2308 2251 2260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g005">Figure 5C</xref>
###xml 300 303 <span type="species:ncbi:12073">CB4</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 556 559 <span type="species:ncbi:12073">CB4</span>
###xml 580 584 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1114 1117 <span type="species:ncbi:12073">CB4</span>
###xml 1405 1409 <span type="species:ncbi:10090">mice</span>
###xml 1631 1635 <span type="species:ncbi:10090">mice</span>
###xml 1646 1649 <span type="species:ncbi:12073">CB4</span>
###xml 1671 1675 <span type="species:ncbi:10090">mice</span>
###xml 1789 1793 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1996 2000 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 2201 2205 <span type="species:ncbi:10090">mice</span>
###xml 2228 2232 <span type="species:ncbi:10090">mice</span>
###xml 2283 2287 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 2388 2392 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
One important functional consequence of TLR ligation with a cognate ligand is the production of pro-inflammatory cytokines and chemokines. Accordingly, we determined the serum levels of cytokines following infection. At 48 hours following infection we measured the levels of IFNalpha in the serum of CB4 infected mice (Figure S6), this production was abrogated in both TLR3KO and MyD88KO mice suggesting that a deficiency in type 1 interferon is unlikely to explain the increased mortality and viral replication observed in TLR3KO mice. At day 4 following CB4 infection of WT NOD mice, we observed significant increases compared to uninfected controls in the levels of both TNF-alpha (Figure 5A) and IL-6 (Figure 5B) and to a lesser extent IFN-gamma (Figure 5C) Little to no production of IL-4, IL-5, IL-10, IL-12p70 was observed following infection (data not shown). TLR3KO mice produced significantly reduced levels of TNF-alpha compared to both WT NOD and MyD88KO mice while the levels of all other cytokines measured were similar to WT NOD mice (Figure 5). This suggests that production of TNF-alpha following CB4 infection is strongly dependent on TLR3 and independent of MyD88. Further, this suggests that TNF-alpha production is critical to the early immune response following infection. Interestingly, we observed a significantly reduced level of IL-6 and IFN-gamma following infection of MyD88KO mice compared to WT NOD indicating that these cytokines are produced following ligation of TLRs other than TLR3 (Figure 5B,C). Further, these data suggest that IL-6 and IFN-gamma do not play a critical role in the survival of mice following CB4 challenge as MyD88KO mice survived infection and controlled viral replication despite reduced levels of both of these cytokines. Following LCMV infection and consistent with prior data [36], we observed a strong cytokine response dominated by the production of IFN-gamma (Figure 5C). It was previously reported that cytokine production following LCMV infection is strongly dependent on the MyD88 pathway [37], [38]. Similarly, we observed a significant reduction of IFN-gamma and TNF-alpha production following infection of MyD88KO compared to WT NOD mice (Figure 5A,B). TLR3KO mice produced comparable levels of IFN-gamma following LCMV challenge (Figure 5C) confirming that this receptor does not play a central role in the response to LCMV.
###end p 25
###begin title 26
###xml 69 72 <span type="species:ncbi:12073">CB4</span>
TLR3 deficiency results in reduced production of TNF-alpha following CB4 infection.
###end title 26
###begin p 27
###xml 224 225 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 215 218 <span type="species:ncbi:12073">CB4</span>
###xml 233 237 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 296 300 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 341 344 <span type="species:ncbi:12073">CB4</span>
Serum levels of A) TNF-alpha, B) IL-6 and C) IFN-gamma from WT NOD (black bars), TLR3KO (white bars) and MyD88KO (grey bars) mice were measured with a CBA inflammation kit 4 days following infection with 400 pfu of CB4, 1x105 pfu of LCMV or mock-infection with DMEM. N =  at least 3 for DMEM and LCMV treatments and n =  at least 5 mice for CB4 treatments. Pooled data from at least 2 independent experiments are presented as mean+/-s.e.m. Stars denote statistical significance.
###end p 27
###begin p 28
###xml 264 272 257 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6</xref>
###xml 345 354 338 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6A</xref>
###xml 367 376 360 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6E</xref>
###xml 400 409 393 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6B</xref>
###xml 421 430 414 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6C</xref>
###xml 619 627 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6</xref>
###xml 742 751 735 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6D</xref>
###xml 1159 1167 1152 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g006">Figure 6</xref>
###xml 62 65 <span type="species:ncbi:12073">CB4</span>
###xml 70 74 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 285 288 <span type="species:ncbi:12073">CB4</span>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 695 699 <span type="species:ncbi:10090">mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 808 811 <span type="species:ncbi:12073">CB4</span>
###xml 940 943 <span type="species:ncbi:12073">CB4</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
###xml 1133 1136 <span type="species:ncbi:12073">CB4</span>
###xml 1262 1266 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 1336 1340 <span type="species:ncbi:10090">mice</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
###xml 1522 1525 <span type="species:ncbi:12073">CB4</span>
###xml 1768 1771 <span type="species:ncbi:12073">CB4</span>
Serum levels of chemokines were investigated at day 4 PI with CB4 and LCMV. Following infection significant increases of CCL2 (MCP-1), CCL3 (MIP-1alpha), CCL4 (MIP1-beta), CCL5 (RANTES) and CXCL9 (MIG) were observed in WT NOD mice compared to uninfected controls (Figure 6). Following CB4 challenge, TLR3KO mice produced similar levels of CCL2 (Figure 6A) and CXCL9 (Figure 6E) while levels of CCL3 (Figure 6B) and CCL4 (Figure 6C) were slightly reduced but were not significantly different from either WT NOD controls or MyD88KO mice suggesting that these chemokines are not critical for survival following infection (Figure 6). Importantly, levels of CCL5 were significantly reduced in TLR3KO mice compared to both WT NOD and MyD88KO mice (Figure 6D) suggesting that production of this chemokine following CB4 challenge is strongly dependent on TLR3 and that production of this chemokine is central to the capacity of the host to control CB4 viral replication. No significant differences in chemokine production were observed between WT NOD and MyD88KO mice following infection further suggesting that the early immune response to CB4 is MyD88 independent (Figure 6). As we observed in the case of the cytokine response, the production of chemokines following LCMV infection was primarily dependent on the MyD88 pathways with MyD88KO mice producing significantly reduced levels of CCL2 and CCL5 compared to WT NOD mice. Taken together, these data demonstrate that the production of some inflammatory mediators following CB4 infection is independent of the MyD88 signaling pathway and strongly dependent on TLR3 signaling. Further, the production of TNF-alpha and CCL5 appear to be critical for the control of viral replication and the survival of the host following CB4 challenge.
###end p 28
###begin title 29
###xml 64 67 <span type="species:ncbi:12073">CB4</span>
TLR3 deficiency results in reduced production of CCL5 following CB4 infection.
###end title 29
###begin p 30
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
###xml 226 229 <span type="species:ncbi:12073">CB4</span>
###xml 244 248 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 307 311 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 352 355 <span type="species:ncbi:12073">CB4</span>
Serum levels of A) CCL2, B) CCL3, C) CCL4, D) CCL5 and E) CXCL9 from WT NOD (black bars), TLR3KO (white bars) and MyD88KO (grey bars) mice were measured with a CBA chemokine flex set 4 days following infection with 400 pfu of CB4, 1x105 pfu of LCMV or mock-infection with DMEM. n =  at least 3 for DMEM and LCMV treatments and n =  at least 5 mice for CB4 treatments. Pooled data from at least 2 independent experiments are presented as mean+/-s.e.m. Stars denote statistical significance.
###end p 30
###begin title 31
###xml 80 83 <span type="species:ncbi:12073">CB4</span>
TLR3 signaling on macrophages plays an important role in the immune response to CB4
###end title 31
###begin p 32
###xml 976 985 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g007">Figure 7A</xref>
###xml 1284 1293 1284 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g007">Figure 7A</xref>
###xml 1769 1778 1769 1778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g007">Figure 7B</xref>
###xml 1852 1861 1852 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004127-g007">Figure 7C</xref>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 648 651 <span type="species:ncbi:12073">CB4</span>
###xml 946 950 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
###xml 1530 1533 <span type="species:ncbi:12073">CB4</span>
###xml 1646 1649 <span type="species:ncbi:12073">CB4</span>
###xml 1846 1850 <span type="species:ncbi:10090">mice</span>
###xml 1884 1888 <span type="species:ncbi:10090">mice</span>
###xml 1941 1945 <span type="species:ncbi:10090">mice</span>
Several cell types including macrophages and DCs are responsible for production of cytokines and chemokines following TLR ligation. In order to determine whether presence of TLR3 on macrophages or DCs was sufficient to decrease the susceptibility of a TLR3 deficient host, adoptive transfer experiments were performed. Splenocytes from WT NOD or TLR3KO mice were purified by flow cytometry in order to obtain two separate populations based on CD11c and CD11b expression. TLR3KO mice were adoptively transferred with a population containing either predominantly macrophages (CD11b+CD11c-) or a population containing DCs (CD11c+) and challenged with CB4 at 24 hours post-transfer. We observed that while adoptive transfer of WT DCs did not confer a survival advantage (data not shown), transfer of WT macrophages resulted in greater survival with the median survival time extended to 20 days compared to 9 days for mock treated and nearly 25% more mice surviving to 21 days PI (Figure 7A). Further, adoptive transfer of WT macrophages conferred a significant survival advantage compared to mice adoptively transferred with macrophages purified from TLR3KO donors with the median survival time extended to 20 days compared to 7.5 days and greater than 35% more mice surviving to day 21 (Figure 7A) confirming that simply increasing the number of macrophages available to respond to virus is not sufficient to confer protection. Instead, TLR3 signaling on macrophages is required to establish protection and ensure survival following CB4 infection. In addition, this suggests that TLR3 signaling on DCs is not sufficient to confer survival following CB4 infection. Importantly, after transfer of WT macrophages, we observed a significant reduction in serum levels of cTn1 (Figure 7B) as well as the number and severity of cardiac lesions in infected mice (Figure 7C) compared to infected mice adoptively transferred with macrophages from TLR3KO mice. This demonstrates that TLR3 signaling on macrophages is critical to prevent viral-mediated cardiac pathology. Furthermore, we observed that protection following adoptive transfer of WT macrophages did not correlate with increased serum levels of TNFalpha or CCL5 (data not shown). These results suggest that macrophages contribute to protection independent of significant increases of these mediators in the periphery and, as expected, macrophages contribute to the antiviral response in a number of ways both globally and locally within the infected tissue.
###end p 32
###begin title 33
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 66 69 <span type="species:ncbi:12073">CB4</span>
Adoptive transfer of WT macrophages rescues TLR3KO mice following CB4 challenge.
###end title 33
###begin p 34
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 221 224 <span type="species:ncbi:12073">CB4</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 432 435 <span type="species:ncbi:12073">CB4</span>
###xml 632 635 <span type="species:ncbi:12073">CB4</span>
###xml 651 655 <span type="species:ncbi:10090">mice</span>
A) TLR3KO mice were adoptively transferred with macrophages from WT NOD mice (dashed black line) or macrophages from TLR3KO mice (solid grey line) or mock-treated with DMEM (solid black line) and infected with 400 pfu of CB4 24 hours post-transfer. B) Serum cardiac troponin 1 levels of TLR3KO mice adoptively transferred with either WT NOD macrophages (black bars, n = 5) or TLR3KO macrophages (white bars, n = 3) at day 7 PI with CB4. Pooled data from at least 2 independent experiments are presented as mean+/-s.e.m. Stars denote statistical significance. C) Representative tissue section of day 7 PI hearts stained for H&E from CB4-infected TL3KO mice adoptively transferred with WT NOD macrophages (left panel) or TLR3KO macrophages (right panel).
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 100 103 <span type="species:ncbi:12073">CB4</span>
###xml 115 119 <span type="species:ncbi:10090">Mice</span>
###xml 423 426 <span type="species:ncbi:12073">CB4</span>
In this study, we demonstrate that TLR3 signaling on macrophages is required for survival following CB4 infection. Mice lacking TLR3 succumb rapidly to viral infection due to uncontrolled viral replication leading to a rapid increase in cardiac damage. Conversely, we observed that MyD88 deficiency did not result in increased mortality suggesting that signaling from other TLRs is not necessary during the early stages of CB4 infection. Our data further highlights the important role of pro-inflammatory mediators, specifically TNF-alpha and CCL5, in controlling viral replication in the host.
###end p 36
###begin p 37
###xml 285 288 285 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Triantafilou1">[3]</xref>
###xml 290 293 290 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Triantafilou2">[5]</xref>
###xml 804 808 804 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Fuse1">[39]</xref>
###xml 1586 1590 1586 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-McCartney1">[19]</xref>
###xml 1592 1596 1592 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Gitlin1">[40]</xref>
###xml 1721 1725 1721 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Schulz1">[21]</xref>
###xml 1763 1767 1763 1767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Kang1">[41]</xref>
###xml 2304 2308 2304 2308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Barral1">[42]</xref>
###xml 2310 2314 2310 2314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Yang1">[43]</xref>
###xml 171 174 <span type="species:ncbi:12073">CB4</span>
###xml 615 618 <span type="species:ncbi:12073">CB4</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 786 803 <span type="species:ncbi:12072">coxsackievirus B3</span>
###xml 925 928 <span type="species:ncbi:12073">CB4</span>
###xml 1135 1138 <span type="species:ncbi:12073">CB4</span>
###xml 1175 1179 <span type="species:ncbi:10090">mice</span>
###xml 1197 1200 <span type="species:ncbi:12073">CB4</span>
###xml 1542 1558 <span type="species:ncbi:357231">murine norovirus</span>
###xml 1581 1585 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 1769 1772 <span type="species:ncbi:12073">CB4</span>
###xml 1912 1915 <span type="species:ncbi:12073">CB4</span>
###xml 2105 2115 <span type="species:ncbi:138953">poliovirus</span>
###xml 2120 2137 <span type="species:ncbi:12092">hepatitis A virus</span>
###xml 2404 2407 <span type="species:ncbi:12073">CB4</span>
In light of the redundancy of innate receptors capable of recognizing virus-associated patterns, it is intriguing that TLR3 plays such a critical in the early response to CB4 infection. Despite the fact that coxsackieviruses have previously been described to signal through other TLRs [3], [5], our results suggests that the other TLRs as well as the other innate viral sensors such as RLHs are unable to compensate for the loss of TLR3. Additionally, our results suggest that not only are other innate viral sensors unable to compensate for the loss of TLR3, they are in fact dispensable for the early response to CB4. This is supported by a report describing that deficiency of MyD88 provided a survival advantage compared to WT mice following challenge with high infectious doses of coxsackievirus B3 [39]. These intriguing observations can be explained by several non-exclusive mechanisms. One likely explanation is that CB4 is recognized by TLRs other than TLR3 but the functional consequences of this interaction are not critical for survival. To this effect, we observed that IL-6 production was significantly reduced following CB4 infection in MyD88KO but not TLR3KO mice, suggesting that CB4 must signal through at least one MyD88-dependent pathway and that the resulting production of IL-6 is not critical for the early control of viral replication. Subcellular localization may explain why the RLHs, in particular MDA-5 which has previously been demonstrated to play an important role in the recognition of other viruses including murine norovirus and the picornavirus, EMCV [19], [40], are unable to compensate for the lack of TLR3. As opposed to TLR3 which is usually localized within endosomal compartments [21], MDA-5 is localized in the cytoplasm [41]. CB4 enters the cell by receptor-mediated endocytosis and therefore would be localized within the endosome rapidly after infection. However, as CB4 is a single stranded virus it seems unlikely that dsRNA intermediates are generated prior to the start of viral replication in the cytoplasm. Alternatively, other picornaviruses, including poliovirus and hepatitis A virus, have been demonstrated to prevent MDA-5 signaling by cleaving either MDA-5 itself or the signaling adaptor molecule mitochondrial antiviral signaling adaptor (MAVS) [42], [43]. Based on these reports, we are currently investigating the interaction between RLHs and CB4 and speculate that this virus may be able to abrogate signaling from RLHs potentially explaining the critical role of TLR3 over the course of infection.
###end p 37
###begin p 38
###xml 1169 1173 1161 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Horwitz1">[34]</xref>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 691 694 <span type="species:ncbi:12073">CB4</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 814 817 <span type="species:ncbi:12073">CB4</span>
###xml 1016 1020 <span type="species:ncbi:10090">mice</span>
###xml 1102 1105 <span type="species:ncbi:12073">CB4</span>
Here, we report that TLR3 deficiency does not affect the activation of several cellular effectors typically involved in the response to viruses including NK cells and APCs. Instead, the absence of TLR3 signaling resulted in significantly reduced levels of the cytokine TNF-alpha and the chemokine CCL5. This suggests that early production of these inflammatory mediators plays a critical role in controlling viral replication and that, in their absence, even the activation of innate effectors and the adaptive response are insufficient to reestablish control of the viral infection. To this effect, we observed that although MyD88 mice present with reduced immune cell activation following CB4 infection, they produce similar levels of TNF-alpha and CCL5 compared to WT mice. The survival of these mice following CB4 infection further highlights the importance of these pro-inflammatory mediators in the control viral replication at the earliest stages of infection. Similarly, it was previously reported that SCID mice, that lack T and B cells, are able to survive the early stages of infection with CB4 suggesting that these cell types are not critical for survival [34].
###end p 38
###begin p 39
###xml 145 153 141 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 158 165 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 179 183 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Herbein1">[44]</xref>
###xml 330 334 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Wada1">[45]</xref>
###xml 554 558 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Hardarson1">[17]</xref>
###xml 833 837 817 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Lowenstein1">[46]</xref>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 380 384 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
TNF-alpha is a pro-inflammatory cytokine produced by several cell types, including macrophages, that has been ascribed antiviral properties both in vitro and in vivo (reviewed in [44]). Wada and colleagues have reported that mice lacking TNF-alpha succumb rapidly to EMCV infection due to increased viral replication in the heart [45], an observation that was supported following EMCV infection of TLR3 deficient mice where reduced TNF-alpha production was observed and correlated with increased viral replication, cardiac damage and increased mortality [17]. The antiviral effects of TNF-alpha may be, in part, mediated by its capacity to induce the production of nitric oxide from macrophages as this molecule has previously been demonstrated to play an important role in the control of coxsackieviral replication within the heart [46]. Taken together with the data presented in this report, this suggests that the TLR3-dependent production TNF-alpha plays a particularly important role in cardiac protection following infection with cardiotropic viruses.
###end p 39
###begin p 40
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Ure1">[47]</xref>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Ure1">[47]</xref>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
###xml 720 723 <span type="species:ncbi:12073">CB4</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
###xml 1087 1090 <span type="species:ncbi:12073">CB4</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
CCL5 is a pro-inflammatory chemokine with chemotactic properties towards both T cells and monocytes/macrophages that is commonly associated with anti-viral responses. Blocking CCL5 activity has previously been demonstrated to result in increased viral antigen in the central nervous system (CNS) of mice following TMEV challenge [47]. Interestingly, normal T cell infiltration was also observed in these mice suggesting that T cells were still able to migrate to the CNS and that the antiviral activity of CCL5 is not simply due to recruitment of T cells [47]. Based on the early mortality observed in our model, it seems unlikely that improper recruitment of T cells is responsible for this increased susceptibility to CB4 infection. Rather, we hypothesize that CCL5 deficiency results in a decrease recruitment of macrophages that may be important for the production of TNF-alpha and, potentially, nitric oxide. To this effect, we observed that the adoptive transfer of a population composed mostly of macrophages but not DCs from WT mice was sufficient to reduce mortality induced by CB4 in TLR3KO mice by preventing viral-mediated cardiac pathology. These data suggest that TLR3 signaling on macrophages results in the production of TNF-alpha and CCL5 both of which act to control early viral replication which, in turn, likely allows for the adaptive immune response to activate and clear the viral infection.
###end p 40
###begin p 41
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Edelmann1">[22]</xref>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Carpentier1">[23]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Hardarson1">[17]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Tam1">[48]</xref>
###xml 761 765 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Weinzierl1">[49]</xref>
###xml 864 868 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Zhang1">[20]</xref>
###xml 215 219 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 694 711 <span type="species:ncbi:12072">coxsackievirus B3</span>
###xml 778 786 <span type="species:ncbi:9606">patients</span>
###xml 1053 1061 <span type="species:ncbi:9606">patients</span>
Contrary to what has been reported for several other viruses including another picornavirus [22], [23], TLR3 signaling plays a role in the protection of the host from cardiotropic viruses such as coxsackievirus and EMCV[17]. Susceptibility to viral-induced myocarditis is dependent on several genetic traits [48]. Our observations suggest that genetic differences leading to changes in TLR3 function or expression could be linked to susceptibility to viral-induced myocarditis. To this effect, it was recently reported that differences in susceptibility to chronic viral-induced myocarditis between a C57Bl/6 and A.BY/SnJ mice was linked with reduced production of TNF-alpha and CCL5 following coxsackievirus B3 infection in a potentially TLR3-dependent manner [49]. Similarly, patients with a TLR3 deficiency are highly susceptible to Herpes Simplex encephalitis [20]. Taken together, these observations suggest that therapies aimed at re-establishing TLR3 signaling or its functional consequences may provide an effective means to protect susceptible patients from suffering the fatal consequences of viral myocarditis.
###end p 41
###begin p 42
###xml 125 142 <span type="species:ncbi:12073">coxsackievirus B4</span>
###xml 748 752 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 757 760 <span type="species:ncbi:12073">CB4</span>
In summary, we provide evidence for an essential non-redundant role for TLR3 signaling on macrophages in the early stages of coxsackievirus B4 infection. Our results demonstrate that the production of important pro-inflammatory mediators such as TNF-alpha and CCL5 are dependent on the TLR3 signaling pathway and independent of the MyD88 pathway. Further, we demonstrate that mortality occurs despite the normal activation of the adaptive immune response. This suggests that in the absence of macrophages recognizing the invading pathogen in a TLR3 dependent manner, viral replication cannot be controlled and is allowed to outpace the developing adaptive immune response. The differences in requirement for TLR3 signaling between RNA viruses (eg. LCMV and CB4) suggest that the wide variety of viral-specific pattern recognition receptors does not represent simple redundancy. Rather this system has been evolved to provide a first-line of defense tailored to the requirements of the host to protect itself against a specific virus. As such, gaining understanding of this complex interplay of viruses with the innate immune system will likely provide insight for the design of more effective antiviral therapeutics.
###end p 42
###begin title 43
Materials and Methods
###end title 43
###begin title 44
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 44
###begin p 45
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
NOD/ShiLtJ and TLR3KO mice were obtained from The Jackson Laboratory (Bar Harbor, USA). TLR3KO mice were backcrossed and maintained on the NOD background. MyD88KO mice on the NOD background were a generous gift from Dr. A. Chervonsky (University of Chicago). All mice were bred and maintained in our rodent facility and monitored for blood glucose prior to infection to ensure that only pre-diabetic mice were analyzed. All performed procedures followed the guidelines of the institutional animal care committee.
###end p 45
###begin title 46
Virus
###end title 46
###begin p 47
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Webb1">[50]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Richer3">[51]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Horwitz2">[52]</xref>
###xml 371 372 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 10 13 <span type="species:ncbi:12073">CB4</span>
###xml 157 161 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 360 363 <span type="species:ncbi:12073">CB4</span>
###xml 380 384 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
Stocks of CB4 Edwards strain 2 was originally obtained from Dr. C. Gauntt (University of Texas-San Antonio) and prepared as described previously [50], [51]. LCMV Armstrong strain 53b was originally obtained from Dr. M.B. Oldstone and propagated as described previously [52]. 6-8 week old mice were infected intraperitoneally with sublethal doses of 400 PFU of CB4 or 1x105 PFU of LCMV. Viral titers were measured following standard plaque assay procedures.
###end p 47
###begin title 48
Flow cytometry
###end title 48
###begin p 49
Single cell suspensions were generated from the spleen at the indicated time points, stained for the appropriate markers and analyzed by flow cytometry. Fluorescently conjugated antibodies directed against CD11b (clone M1/70), CD11c (clone HL3), CD4 (clone L3T4), CD8 (clone 53-6.7), CD19 (clone eBio 1D3), panNK (clone DX5) and CD69 (clone H1.2F3) were purchased from eBiosciences (San Diego, USA) while biotin conjugated antibodies directed against CD44 (clone IM7), CD62L (clone Mel-14), CD69 (clone H1.2F3), CD80 (clone 16-10A1) and, CD86 (clone GL1) were purchased from BD Biosciences (Missisauga, Canada).
###end p 49
###begin title 50
Immunohistochemical staining
###end title 50
###begin p 51
###xml 54 58 54 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004127-Richer3">[51]</xref>
Tissue sections were prepared as previously described [51] at day 7 PI. Staining was performed using standard procedures for hematoxylin and eosin (Wax-It, Vancouver, British Columbia). Tissue sections were graded for pathology.
###end p 51
###begin title 52
Quantitative measurement of liver damage
###end title 52
###begin p 53
Liver damage was quantified at days 3 and 7 PI by measuring serum levels of alanine transaminase (ALT) using commercially available Infinitytrade mark ALT reagents (Thermo Scientific, Waltham, MA) according to manufacturer's instructions.
###end p 53
###begin title 54
Quantitative measurement of heart damage
###end title 54
###begin p 55
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Heart damage was quantified by measuring release of cardiac troponin 1 into the serum of mock-infected or infected mice at days 3 and 7 PI using a commercially available ELISA kit (Life Diagnostics, West Chester, PA) according to manufacturer's instruction.
###end p 55
###begin title 56
Cytokine and chemokine analysis
###end title 56
###begin p 57
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
###xml 620 625 <span type="species:ncbi:10090">Mouse</span>
Serum cytokine and chemokine levels were measured at day 4 PI using a mouse inflammation CBA kit (BD Bioscience) allowing for simultaneous detection IL-6, IL-10, MCP-1, IFN-gamma, TNF-alpha and IL-12p70 from a single sample or a chemokine flex set (BD Bioscience) customized to allow for simultaneous detection of CXCL9 (MIG), CCL3 (MIP1alpha), CCL4 (MIP1beta) and CCL5 (RANTES) from a single sample. Samples were prepared according to manufacturer's instructions and analyzed on a BDFacsArray equipped with FCAP software (BDBiosciences). Serum levels of IFNalpha were measured at 48 hours PI using a VeriKinetrade mark Mouse interferon alpha kit (PBL interferon source, Piscataway, NJ) according to manufacturer's instructions.
###end p 57
###begin title 58
Adoptive transfer experiments
###end title 58
###begin p 59
###xml 246 247 246 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 373 374 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 466 467 466 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 546 549 <span type="species:ncbi:12073">CB4</span>
Splenic single cell suspension from uninfected WT NOD or TLR3KO mice were stained with fluorescently conjugated antibodies specific for CD11b and CD11c. Cells were sorted by FACS into two separate populations composed mainly of macrophages (CD11b+CD11c-) or mainly dendritic cells (CD11c+ with varying expression of CD11b). TLR3KO mice were adoptively transferred with 2x105 and a number of DCs corresponding to the natural ratio of these cells compared to the CD11b+CD11c- group (between 70,000 to 150,000) intraperitoneally and challenged with CB4 24 hours post-transfer.
###end p 59
###begin title 60
Statistical Analysis
###end title 60
###begin p 61
Kaplan-Meier analysis was used to compare survival curves and unpaired Student's t-test was used for all other analyses. A P value of <0.05 was considered significant.
###end p 61
###begin title 62
Supporting Information
###end title 62
###begin p 63
###xml 89 92 <span type="species:ncbi:12073">CB4</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 459 462 <span type="species:ncbi:12073">CB4</span>
MyD88 deficiency decreases the capacity of cellular effectors to activate in response to CB4 infection. Representative histograms of expression of activation or costimulatory marker (as indicated) on the surface of A) NK cells (Pan-NK+, TCRbeta -), B) NK T cells (Pan-NK+, TCRbeta +), C) macrophages (CD11b+CD11c-), D) dendritic cells (CD11c+), E) B cells (CD19+), F) CD4+ T cells and G) CD8+ T cells from MyD88KO mice at day 4 post-infection with 400 pfu of CB4 (solid black lines) or mock-infection with DMEM (shaded histogram). Data is representative of at least 2 separate experiments.
###end p 63
###begin p 64
(0.70 MB TIF)
###end p 64
###begin p 65
Click here for additional data file.
###end p 65
###begin p 66
###xml 73 77 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
TLR3 deficiency does not affect the capacity of APCs to mature following LCMV infection. Representative histograms of CD80 and CD86 expression on the surface of (A) macrophages (CD11b+CD11c-) and (B) dendritic cells (CD11c+) from WT NOD (left panels) and TLR3KO (right panels) mice at 4 days post-infection with 1x105 pfu of LCMV (solid black lines) or mock-infection with DMEM (shaded histogram). Data is representative of at least 2 separate experiments.
###end p 66
###begin p 67
(0.59 MB TIF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
###xml 78 81 <span type="species:ncbi:12073">CB4</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 279 282 <span type="species:ncbi:12073">CB4</span>
TLR3 deficiency does not affect the capacity of B cells to activate following CB4 infection. Representative histograms of CD69 and CD86 expression on the surface of B cells (CD19+) from WT NOD (left panels) and TLR3KO (right panels) mice at 4 days post-infection with 400 pfu of CB4 (solid black lines) or mock-infection with DMEM (shaded histogram). Data is representative of at least 2 separate experiments.
###end p 69
###begin p 70
(0.33 MB TIF)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
###xml 78 82 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
TLR3 deficiency does not affect the capacity of T cells to activate following LCMV infection. Representative histograms of CD62L and CD69 expression on the surface of (A) CD4 and (B) CD8 T cells from WT NOD (left panels) and TLR3KO (right panels) mice at 4 days post-infection with 1x105 pfu of LCMV (solid black lines) or mock-infection with DMEM (shaded histogram). Data is representative of at least 2 separate experiments.
###end p 72
###begin p 73
(0.61 MB TIF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
###xml 60 64 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
###xml 68 71 <span type="species:ncbi:12073">CB4</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 284 287 <span type="species:ncbi:12073">CB4</span>
###xml 330 334 <span type="species:ncbi:11623?0.9953846153846154">LCMV</span>
TLR3 deficiency does not affect T cell activation following LCMV or CB4 infection. Representative histograms of CD44 expression on the surface of (A, C) CD4 and (B, D) CD8 T cells from WT NOD (left panels) and TLR3KO (right panels) mice at 7 days post-infection with (A,B) 400 pfu of CB4 (solid black lines) or (C,D) 1x105 pfu of LCMV (solid black lines) or mock-infection with DMEM (shaded histogram). Data is representative of at least 2 separate experiments.
###end p 75
###begin p 76
(0.61 MB TIF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
###xml 50 53 <span type="species:ncbi:12073">CB4</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
Type 1 interferon production is reduced following CB4 infection in both TLR3KO and MyD88KO mice. Serum levels of IFNalpha from WT NOD (black bars), TLR3KO (white bars) and MyD88KO (grey bars) mice were measured with a VeriKine Elisa Kit at 48 hours following infection with 400 pfu of N =  at least 7 for each group. Pooled data from at least 2 independent experiments are presented as mean+/-s.e.m.
###end p 78
###begin p 79
(0.20 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
###xml 87 91 <span type="species:ncbi:10090">mice</span>
The authors would like to thank Dr. A. Chervonsky for his generous gift of the MyD88KO mice on the NOD background. We would also like to thank A. Johnson and C, Casiraghi for technical assistance and Dr. N. Abraham, Dr. K.W. Harder, S.A. Condotta M.Sc. and L.C. Osborne for useful discussion and critical reading of the manuscript.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
###xml 0 21 <span type="species:ncbi:10359">Human cytomegalovirus</span>
Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells.
###end article-title 83
###begin article-title 84
###xml 0 26 <span type="species:ncbi:11276">Vesicular stomatitis virus</span>
Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway.
###end article-title 84
###begin article-title 85
###xml 0 17 <span type="species:ncbi:12073">Coxsackievirus B4</span>
Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4.
###end article-title 85
###begin article-title 86
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
###end article-title 86
###begin article-title 87
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent.
###end article-title 87
###begin article-title 88
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.
###end article-title 88
###begin article-title 89
Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells.
###end article-title 89
###begin article-title 90
TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
###end article-title 90
###begin article-title 91
Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
###end article-title 91
###begin article-title 92
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.
###end article-title 92
###begin article-title 93
Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
###end article-title 93
###begin article-title 94
###xml 84 89 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
###end article-title 94
###begin article-title 95
###xml 69 74 <span type="species:ncbi:9606">human</span>
Toll-like receptor 3 agonist poly(I:C)-induced antiviral response in human corneal epithelial cells.
###end article-title 95
###begin article-title 96
###xml 64 91 <span type="species:ncbi:10310">herpes simplex virus type 2</span>
Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.
###end article-title 96
###begin article-title 97
Astrocyte indoleamine 2,3-dioxygenase is induced by the TLR3 ligand poly(I:C): mechanism of induction and role in antiviral response.
###end article-title 97
###begin article-title 98
Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
###end article-title 98
###begin article-title 99
Toll-like receptor 3 is an essential component of the innate stress response in virus-induced cardiac injury.
###end article-title 99
###begin article-title 100
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
###end article-title 100
###begin article-title 101
###xml 23 39 <span type="species:ncbi:357231">murine norovirus</span>
MDA-5 recognition of a murine norovirus.
###end article-title 101
###begin article-title 102
###xml 19 27 <span type="species:ncbi:9606">patients</span>
TLR3 deficiency in patients with herpes simplex encephalitis.
###end article-title 102
###begin article-title 103
Toll-like receptor 3 promotes cross-priming to virus-infected cells.
###end article-title 103
###begin article-title 104
Does Toll-like receptor 3 play a biological role in virus infections?
###end article-title 104
###begin article-title 105
Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli.
###end article-title 105
###begin article-title 106
###xml 61 78 <span type="species:ncbi:11320">influenza A virus</span>
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.
###end article-title 106
###begin article-title 107
TLR3 deletion limits mortality and disease severity due to Phlebovirus infection.
###end article-title 107
###begin article-title 108
###xml 30 45 <span type="species:ncbi:11082">West Nile virus</span>
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis.
###end article-title 108
###begin article-title 109
###xml 51 66 <span type="species:ncbi:11082">West Nile virus</span>
Toll-like receptor-3 has a protective role against West Nile virus infection.
###end article-title 109
###begin article-title 110
Viral infections in the pathogenesis of autoimmune diseases: focus on type 1 diabetes.
###end article-title 110
###begin article-title 111
Autoimmunity in coxsackievirus infection.
###end article-title 111
###begin article-title 112
Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007.
###end article-title 112
###begin article-title 113
###xml 44 49 <span type="species:ncbi:9606">child</span>
Isolation of a virus from the pancreas of a child with diabetic ketoacidosis.
###end article-title 113
###begin article-title 114
Regulatory T-cells protect from type 1 diabetes after induction by coxsackievirus infection in the context of transforming growth factor-beta.
###end article-title 114
###begin article-title 115
Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets.
###end article-title 115
###begin article-title 116
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 68 85 <span type="species:ncbi:12072">coxsackievirus B3</span>
Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
###end article-title 116
###begin article-title 117
Release kinetics of serum cardiac troponin I in ischemic myocardial injury.
###end article-title 117
###begin article-title 118
###xml 40 74 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo.
###end article-title 118
###begin article-title 119
###xml 83 117 <span type="species:ncbi:11623">lymphocytic choriomeningitis virus</span>
MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection.
###end article-title 119
###begin article-title 120
Lymphocytoid choriomeningitis virus activates plasmacytoid dendritic cells and induces a cytotoxic T-cell response via MyD88.
###end article-title 120
###begin article-title 121
###xml 78 95 <span type="species:ncbi:12072">Coxsackievirus B3</span>
Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
###end article-title 121
###begin article-title 122
Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus.
###end article-title 122
###begin article-title 123
mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.
###end article-title 123
###begin article-title 124
###xml 20 30 <span type="species:ncbi:138953">poliovirus</span>
MDA-5 is cleaved in poliovirus-infected cells.
###end article-title 124
###begin article-title 125
Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
###end article-title 125
###begin article-title 126
Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis.
###end article-title 126
###begin article-title 127
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha.
###end article-title 127
###begin article-title 128
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Nitric oxide inhibits viral replication in murine myocarditis.
###end article-title 128
###begin article-title 129
Neutralization of chemokines RANTES and MIG increases virus antigen expression and spinal cord pathology during Theiler's virus infection.
###end article-title 129
###begin article-title 130
Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.
###end article-title 130
###begin article-title 131
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
Effective chemokine secretion by dendritic cells and expansion of cross-presenting CD4-/CD8+ dendritic cells define a protective phenotype in the mouse model of coxsackievirus myocarditis.
###end article-title 131
###begin article-title 132
###xml 18 22 <span type="species:ncbi:10090">mice</span>
Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene.
###end article-title 132
###begin article-title 133
Toll-like receptor 4-induced cytokine production circumvents protection conferred by TGF-beta in coxsackievirus-mediated autoimmune myocarditis.
###end article-title 133
###begin article-title 134
Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry.
###end article-title 134
###begin p 135
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 135
###begin p 136
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Canadian Institute of Health Research and Michael Smith Foundation for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 136

